Adult Diabetes Type 2

Adult Diabetes Type 2

Type 2 diabetes is a progressive disease characterized by insulin deficiency and a deterioration of the response of target tissues, over time, causes loss of beta cell function and, therefore, a progressive deterioration in the glycemic control regardless of the treatment used with the therapeutic arsenal available so far (Beran, et. al., 2013).

Although it is an increasing problem worldwide, almost half of the cases of type 2 diabetes are undiagnosed due to lack of regular medical examinations or ignorance. At this time and with the available data, the prevalence of this disease in our environment could be around 10% of the population and, by 2025, the World Health Organization (WHO) predicts an increase of 50% of the incidence of this disease, especially in South America, Southeast Asia and Sub-Saharan Africa (Shaw, Sicree, Zimmet, 2010).

Discussion

Medical decisions in type 2 diabetes patients reach ten years of delay, which means that, when the patient is diagnosed, the function of pancreatic beta cells already committed up to 50%, and also in years after diagnosis, the decline in beta cell function continues (Currie, et. al., 2012). In 2025 it is expected that the number of patients will increase to 380 million people with type 2 diabetes. Of them each year, 3.8 million people worldwide die from diabetes or complications from the disease (Currie, et. al., 2012).

Only 29% of health spending is devoted to diabetes, while 40% is for treatment of complications associated with this disease. In fact, patients with type 2 associated with complications and comorbidities diabetes are 2.4 times more costly to the system that those without complications, since pharmaceutical expenditure in insulin and oral anti-diabetic represents only 12% of spending the treatment of type 2 diabetes (Currie, et. al., 2012).

It is important to diagnose as early as possible the presence of the disease to act as soon as possible using the available tools and some, promising to come. The pathophysiology of diabetes is increasingly complicated and there are a greater number of factors involved. This forces us to treat diabetes with a multifactorial and multidisciplinary approach since, what we're doing so far, have not achieved good control and need, Beren clearly states in his study, to preserve the function of the beta cell to improve quality of life of patients and prevent comorbidities (Beran, et. al., 2013).

Type

The two major types of diabetes: type 1 diabetes - Is one ...